pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Gene Therapy (AAV) · news · pharmadog
← back to Gene Therapy (AAV)
News · Gene Therapy (AAV)
221
stories
May 12, 26
Flagship startup Serif says it has solved non-viral gene therapy in monkeys
endpoints
May 11, 26
STAT+: Astellas treatment offers new hope to a devastated rare disease community
stat
May 11, 26
Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
biopharma dive
May 11, 26
European regulators greenlight Fractyl Health's clinical test of GLP-1 gene therapy
endpoints
May 11, 26
The capacity crunch in biopharma is a location problem
biopharma dive
May 11, 26
STAT+: Five years after disaster, a rare disease community gets new chance at treatment
stat
May 7, 26
Sarepta tumbles as its gene therapy sales decline further
biopharma dive
May 7, 26
STAT+: FDA to reconsider treatment for rare cancer after its surprise rejection
stat
May 7, 26
STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
stat
May 6, 26
STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price
stat
May 6, 26
HHS tackles ‘overmedication’
stat
May 6, 26
STAT+: Even at a meeting in Rome, FDA shifts are top of mind for gene therapy field
stat
May 5, 26
Second life for gene therapy; Takeda Phase 2/3 win; UK cancer biotech's $83M
endpoints
May 4, 26
With $97M, Latus pursues a different kind of Huntington’s gene therapy
biopharma dive
May 4, 26
UCB to acquire maker of antibody treatments for autoimmune diseases
stat
May 4, 26
STAT+: Biotech raises $42 million to run Huntington’s disease trial
stat
Apr 30, 26
STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center
stat
Apr 30, 26
UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy
biopharma dive
Apr 30, 26
STAT+: Five-way obesity drug is super effective — in mice
stat
Apr 28, 26
STAT+: FDA launches effort to speed up clinical trials, using AI
stat
Apr 28, 26
Fauci adviser David Morens indicted on charges of concealing emails, avoiding records requests
stat
Apr 28, 26
Rocket's PRV goes for $180M; Oruka targets $500M offering
endpoints
Apr 28, 26
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
biopharma dive
Apr 28, 26
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
stat
Apr 28, 26
STAT+: Eli Lilly enlists AI startup for next-generation gene editors
stat
Apr 27, 26
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
stat
Apr 27, 26
STAT+: An insider reveals the real goals of prior authorization
stat
Apr 27, 26
STAT+: Astellas retries XLMTM gene therapy after deaths
stat
Apr 27, 26
Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder
biopharma dive
Apr 27, 26
STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depression
stat
← prev
page 7 of 8
next →
